Experience with multiple approaches to the prenatal diagnosis of the fragile X syndrome: Amniotic fluid, chorionic villi, fetal blood and molecular methods
Lawrence R. Shapiro, W. Roy Breg(Yale University), Patricia D. Murphy(Newark Beth Israel Medical Center), Patrick L. Wilmot(Westchester Medical Center)
Cited by 22
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
|New England Journal of Medicine|2000|726
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292
Genetic Information and the Workplace: Legislative Approaches and Policy Challenges
|Science|1997|153
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
|PLoS Pathogens|2016|78